Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Journal of Biopharmaceutical Statistics
|
June 4, 2024
Biomarker-driven basket trial designs: origins and new methodological developments
Yue Tu, Lindsay A Renfro
Therapeutic Innovation & Regulatory Science
|
September 13, 2024
Latest Developments in "Adaptive Enrichment" Clinical Trial Designs in Oncology
Yue Tu, Lindsay A Renfro
Journal of Biopharmaceutical Statistics
|
September 7, 2017
Definitions and statistical properties of master protocols for personalized medicine in oncology
Lindsay A Renfro, Sumithra J Mandrekar
Chinese Clinical Oncology
|
January 8, 2017
Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials
Lindsay A Renfro, Daniel J Sargent
Journal of Biopharmaceutical Statistics
|
June 7, 2014
Impact of Copula Directional Specification on Multi-Trial Evaluation of Surrogate End Points
Lindsay A Renfro, Hongwei Shang, Daniel J Sargent
Chinese Clinical Oncology
|
April 6, 2015
Mining the ACCENT database: a review and update
Lindsay A Renfro, Qian Shi, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2016
Surrogate End Points in Soft Tissue Sarcoma: Methodologic Challenges
Lindsay A Renfro, Qian Shi, Daniel J Sargent
Biometrics
|
August 20, 2021
Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects
Yusha Liu, John A Kairalla, Lindsay A Renfro
Biometrics
|
August 16, 2011
Bayesian adaptive trial design for a newly validated surrogate endpoint
Lindsay A Renfro, Bradley P Carlin, Daniel J Sargent
Cancer Letters
|
March 19, 2016
Precision oncology: A new era of cancer clinical trials
Lindsay A Renfro, Ming-Wen An, Sumithra J Mandrekar
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Journal of Biopharmaceutical Statistics
|
June 4, 2024
Biomarker-driven basket trial designs: origins and new methodological developments
Yue Tu, Lindsay A Renfro
Therapeutic Innovation & Regulatory Science
|
September 13, 2024
Latest Developments in "Adaptive Enrichment" Clinical Trial Designs in Oncology
Yue Tu, Lindsay A Renfro
Journal of Biopharmaceutical Statistics
|
September 7, 2017
Definitions and statistical properties of master protocols for personalized medicine in oncology
Lindsay A Renfro, Sumithra J Mandrekar
Chinese Clinical Oncology
|
January 8, 2017
Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials
Lindsay A Renfro, Daniel J Sargent
Journal of Biopharmaceutical Statistics
|
June 7, 2014
Impact of Copula Directional Specification on Multi-Trial Evaluation of Surrogate End Points
Lindsay A Renfro, Hongwei Shang, Daniel J Sargent
Chinese Clinical Oncology
|
April 6, 2015
Mining the ACCENT database: a review and update
Lindsay A Renfro, Qian Shi, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2016
Surrogate End Points in Soft Tissue Sarcoma: Methodologic Challenges
Lindsay A Renfro, Qian Shi, Daniel J Sargent
Biometrics
|
August 20, 2021
Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects
Yusha Liu, John A Kairalla, Lindsay A Renfro
Biometrics
|
August 16, 2011
Bayesian adaptive trial design for a newly validated surrogate endpoint
Lindsay A Renfro, Bradley P Carlin, Daniel J Sargent
Cancer Letters
|
March 19, 2016
Precision oncology: A new era of cancer clinical trials
Lindsay A Renfro, Ming-Wen An, Sumithra J Mandrekar
Page
of 8